Health Care & Life Sciences » Pharmaceuticals | Extrawell Pharmaceutical Holdings Ltd.

Extrawell Pharmaceutical Holdings Ltd. | Cash Flow

Fiscal year is April-March. All values HKD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
34,046.00
555,397.00
27,490.00
18,927.00
29,186.00
Depreciation, Depletion & Amortization
2,940.00
6,029.00
6,294.00
6,427.00
6,327.00
Other Funds
18,700.00
-
-
-
-
Funds from Operations
1,559.00
13,578.00
31,533.00
17,493.00
20,973.00
Changes in Working Capital
67,150.00
8,897.00
597.00
14,313.00
2,300.00
Net Operating Cash Flow
65,591.00
22,475.00
32,130.00
31,806.00
23,273.00
Capital Expenditures
139,266.00
4,596.00
481.00
1,008.00
124.00
Sale of Fixed Assets & Businesses
74,997.00
75,279.00
71.00
-
-
Purchase/Sale of Investments
-
6.00
3,012.00
1,124.00
80,000.00
Net Investing Cash Flow
76,376.00
70,525.00
3,422.00
3,071.00
80,124.00
Net Financing Cash Flow
18,700.00
-
-
-
-
Net Change in Cash
32,754.00
48,531.00
28,853.00
36,967.00
55,751.00
Free Cash Flow
73,675.00
27,071.00
31,649.00
30,798.00
23,149.00
Net Assets from Acquisitions
12,000.00
-
-
-
-
Other Sources
-
-
-
2,955.00
-
Exchange Rate Effect
3,269.00
481.00
145.00
2,090.00
1,100.00
Other Uses
107.00
152.00
-
-
-

About Extrawell Pharmaceutical Holdings

View Profile
Address
Suites 2206-08, 22/F
Hong Kong
Hong Kong
Employees -
Website http://www.extrawell.com.hk
Updated 07/08/2019
Extrawell Pharmaceutical Holdings Ltd. engages in the marketing and distribution of pharmaceutical products. It operates through the following segments: Manufacturing, Trading, and Gene Development. The Manufacturing segment includes the development, manufacture, and sale of pharmaceutical products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.